ICER Asthma Report
Obesity Threatens to Roll Back Progress Against Cancer
America faces a good news-bad news situation, according to the newly published annual report from the American Cancer Society.
Summer Brings Unusual Spike in Children’s Respiratory Virus
Warm summer months usually provide a break from respiratory syncytial virus. But not this year.
Embracing Biosimilars
I know some people who are brand loyal because they are hesitant to change. I, however, am not one of them. And I take that approach in prescribing biologics and biosimilars for my patients, too.
Balancing Telehealth and In-Person Care
By David Charles, MD “I’m never coming back into the office again!” That’s how one of my patients responded after his first virtual doctor’s visit last year. I hope he’s wrong. Don’t misunderstand me. Telehealth is a powerful and important tool. Its value during the pandemic can hardly be understated. Going forward, it will […]
ICER Crosses the Center Line
The admonition to the Institute for Clinical and Economic Review’s Beacon Hill economists should be quite simple: “Stay in your lane.”
Rx Exclusion Lists Shut Patients Out
Health plans are quietly cutting more and more medications from their list of approved drugs, narrowing patients’ treatment options.
Migraine Care at Work: Helping Women, Helping Everyone
Many people still equate migraine with “bad headaches.” But in fact, migraine is a chronic, debilitating disease that afflicts 47 million Americans, 75% of whom are women.
California Insurer Rethinks Restrictions on Cholesterol Medication
Californians in danger of a heart attack or stroke now have help reducing a key risk factor.
New Insurance Strategy Pits Patients Against Their Pocketbooks
Which would you choose – $500 or the medication that effectively manages your condition? It’s a tough choice, but one that patients across the country now face.
